Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02952703 · ClinicalTrials.gov registry record · NA
Disseminating and Implementing a Smoking Cessation Program for Pregnant and Postpartum Women
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 185
- Enrollment target
NCT02952703: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT02952703 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 185 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02952703, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 185 participants
- Enrollment target
Study Summary
This study tests whether a smoking cessation intervention for pregnant women that extends postpartum (Striving to Quit (STQ)) can be implemented and disseminated outside of the research environment that established its effectiveness (40% maintained biochemically verified 6-month abstinence). The research aim is: Is Striving to Quit more effective in achieving postpartum smoking cessation than "First Breath," the current standard of care for pregnant women in Wisconsin who smoke? 250 women will be randomized into one of two study groups. Pregnant women in Group A (n=125) will receive the existing First Breath prenatal intervention. Those in Group B (Striving to Quit (STQ), n=125) will receive all Group A interventions, plus 1 additional prenatal home visit, 3 postpartum in-home smoking cessation counseling visits, 3 postpartum phone calls, and up to an additional $100 in gift cards. The primary outcome will be biochemically confirmed smoking cessation at 6-months postpartum.
Primary Outcome
Biochemically verified smoking abstinence: Breath Carbon Monoxide (CO)\<9ppm
Interventions
- BEHAVIORAL brief pre-delivery smoking cessation counseling
- BEHAVIORAL additional pre-delivery smoking cessation counseling
- BEHAVIORAL post- delivery smoking cessation counseling
- BEHAVIORAL incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-05 |
| Phase | NA |
What the finished NCT02952703 record still lists
NCT02952703 is an interventional study that assigns participants to a tested intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 4 interventions - of which brief pre-delivery smoking cessation counseling is the first listed.
NCT02952703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02952703 about?
NCT02952703 is a clinical study titled "Disseminating and Implementing a Smoking Cessation Program for Pregnant and Postpartum Women". This study tests whether a smoking cessation intervention for pregnant women that extends postpartum (Striving to Quit (STQ)) can be implemented and disseminated outside of the research environment that established its effectiveness (40% maintained biochemically verified 6-month abstinence). The res...
What is the current status of trial NCT02952703?
This trial is currently completed. It is a NA study. The enrollment target is 185 participants. The study started on 2016-11. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02952703?
The interventions under investigation include: brief pre-delivery smoking cessation counseling (BEHAVIORAL), additional pre-delivery smoking cessation counseling (BEHAVIORAL), post- delivery smoking cessation counseling (BEHAVIORAL), incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT02952703?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02952703's enrollment target sits among peer trials
185 580th of 2000 higher than 1,420 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia